Skip to main content

Solanopubamine

ADVERTISEMENT
Identification
Molecular formula
C18H22O2
CAS number
55779-62-1
IUPAC name
3-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one
State
State

Solid at room temperature, specifically existing as a crystalline powder typically utilized in research and development settings.

Melting point (Celsius)
230.00
Melting point (Kelvin)
503.15
Boiling point (Celsius)
489.00
Boiling point (Kelvin)
762.15
General information
Molecular weight
270.42g/mol
Molar mass
270.4210g/mol
Density
1.1000g/cm3
Appearence

Solanopubamine appears as a white to off-white crystalline powder. It is known for its relatively stable nature in solid form, maintaining its integrity under standard room conditions.

Comment on solubility

Solubility of 3-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one

The solubility of 3-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one (C18H22O2) can be intriguing due to its complex molecular structure. Here are some key points to consider:

  • Polar vs. Non-Polar Solvents: This compound, having a hydroxyl group, may exhibit some degree of solubility in polar solvents such as alcohols, although it is predominantly hydrophobic due to its larger hydrocarbon framework.
  • Temperature Influence: Solubility can increase with temperature; thus, heating the solvent may enhance the dissolution process.
  • Effects of pH: The solubility of compounds with hydroxyl (-OH) groups can also be affected by the pH of the solution, impacting their ionization and thus their solubility characteristics.
  • Practical Applications: Understanding its solubility is crucial for applications in fields such as pharmaceuticals and material science, where dissolution characteristics can influence bioavailability and material performance.

Overall, due to its structural features, 3-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one may present moderate solubility in specific organic solvents while remaining quite insoluble in water.

Interesting facts

3-Hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one

This intriguing compound, often found in discussions surrounding natural products and steroids, presents a fascinating study in both its structure and potential applications. Here are some captivating aspects of this compound:

  • Structural Complexity: The compound exhibits a unique cyclopenta[a]phenanthrene core, a characteristic feature that contributes to its interesting chemical properties and biological activities.
  • Bioactivity: Compounds of this type have been investigated for their potential biological activities, including anti-inflammatory and analgesic effects. This has sparked interest in their use in medicinal chemistry.
  • Synthetic Pathways: The synthesis of such polycyclic compounds can be quite elaborate. Researchers continually explore innovative synthetic pathways to improve efficiency or yield, often using advanced catalytic methods.
  • Natural Occurrence: Variations of this compound may be found naturally in certain plants and fungi, indicating a role in ecological interactions or as a secondary metabolite.
  • Research Opportunities: The study of 3-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one opens a myriad of research opportunities in fields such as pharmacology and organic chemistry

In conclusion, the complexity and diverse biological implications of 3-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one make it a compound of significant academic interest. As stated by one prominent chemist, "The beauty of organic chemistry lies in the intricate structures that nature provides us, waiting to be understood." Understanding such compounds fosters advancements in both theoretical knowledge and practical applications in the realm of science.

Synonyms
SR-05000001615
DTXSID90859387
Spectrum_000285
Spectrum2_000746
Spectrum3_000416
Spectrum4_001635
Spectrum5_000449
BSPBio_001972
KBioGR_002069
KBioSS_000765
DivK1c_000812
SPECTRUM1500275
SPBio_000732
CHEMBL1474552
SCHEMBL14136188
CHEBI:91940
HMS502I14
KBio1_000812
KBio2_000765
KBio2_003333
KBio2_005901
KBio3_001192
NINDS_000812
WKRLQDKEXYKHJB-UHFFFAOYSA-N
HMS1920K18
HMS2094I15
Pharmakon1600-01500275
CCG-40143
NSC756756
NSC-756756
3-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one
IDI1_000812
NCGC00094667-01
NCGC00094667-02
NCGC00094667-03
NCGC00178887-01
SBI-0051364.P003
DB-051455
AB00051978_02
SR-05000001615-1
SR-05000001615-2
BRD-A88080608-001-01-8
BRD-A88080608-001-03-4
BRD-A88080608-001-04-2
Q27163738